Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Cidara Therapeutics Inc (CDTX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Cidara Therapeutics Inc's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.722 -0.000    -0.03%
18/04 - Closed. Currency in USD ( Disclaimer )
After Hours
0.770
+0.048
+6.648%
0:59:58 - Real-time Data
  • Volume: 271,459
  • Bid/Ask: 0.720 / 0.770
  • Day's Range: 0.715 - 0.750
Type:  Equity
Market:  United States
Cidara Therapeutics Inc 0.722 -0.000 -0.03%

CDTX Share Price Overview

 
Assess today's live Cidara Therapeutics Inc (CDTX) share price, performance and insights using our live NASDAQ: CDTX stock exchange data.

Analyse the historical data and Cidara Therapeutics Inc share price performance charts on this page. Our technical summary section provides analysis on Cidara Therapeutics Inc share price buy/sell indicators using real-time data (or discuss the Cidara Therapeutics Inc (CDTX) stock price today with other investors in the Cidara Therapeutics Inc NASDAQ share price and sentiment chat forum).

Use the dropdown to select a relevant stock exchange for the current NASDAQ CDTX share price (ISIN: US1717571079) to enhance your trading decisions with our free investment tools and resources.

What Is the Cidara Therapeutics Inc Share Price Today?
The Cidara Therapeutics Inc share price today is 0.722.

What Is the Stock Symbol for Cidara Therapeutics Inc
The stock symbol (or 'ticker') for Cidara Therapeutics Inc is "CDTX."

What Stock Exchange Does Cidara Therapeutics Inc Trade On?
Cidara Therapeutics Inc is listed and trades on the NASDAQ stock exchange.

Is Cidara Therapeutics Inc a Good Stock to Buy?
Determining whether Cidara Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close0.722
Day's Range0.715 - 0.75
Revenue56.54M
Open0.72
52 wk Range0.593 - 1.48
EPS - 0.371
Volume271,459
Market Cap65.43M
Dividend (Yield)N/A (N/A)
Average Volume (3m)704,841
P/E Ratio - 1.94
Beta0.926
1-Year Change - 35.54%
Shares Outstanding90,619,040
Next Earnings DateMay 09, 2024
What is your sentiment on Cidara Therapeutics Inc?
or
Market is currently closed. Voting is open during market hours.

Cidara Therapeutics Inc News Today


Technical Summary

Type 5 Min 15 Min Hourly Daily Monthly
Moving Averages Strong Sell Strong Sell Strong Sell Strong Sell Strong Sell
Technical Indicators Sell Strong Sell Strong Sell Strong Sell Strong Sell
Summary Strong Sell Strong Sell Strong Sell Strong Sell Strong Sell

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Belt Hold Bearish 30 Current
Completed Patterns
Bullish doji Star 1D 1 Apr 17, 2024
Three Inside Up 30 1 Apr 18, 2024 20:00
Dragonfly Bearish 15 2 Apr 18, 2024 20:15

Trending Stocks

Create Alert
Add to Watchlist
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  IAG 169.80 187.90 163.55 +9.10 +5.66% 35.30M 18/04  
  Rolls-Royce Holdings 402.50 406.71 398.30 +1.10 +0.27% 34.65M 18/04  
  EasyJet 530.00 547.00 526.40 +11.80 +2.28% 15.43M 18/04  
  Lloyds Banking 51.00 51.30 50.62 +0.58 +1.15% 95.48M 18/04  
  BP 512.40 515.10 508.20 -4.40 -0.85% 36.63M 18/04  
  Ocado 350.00 350.50 3.48 +1.80 +0.52% 3.54M 18/04  
  Centamin 128.10 129.50 120.10 -1.60 -1.23% 10.66M 18/04  
  Barclays 183.98 183.98 181.14 +4.04 +2.25% 72.90M 18/04  
  HSBC 644.60 645.60 637.60 +8.50 +1.34% 44.84M  
  BAE Systems 1,287.00 1,316.50 1,272.50 -33.00 -2.50% 11.50M 18/04  

%SHORT_NAME% Company Profile

IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

89

Equity Type

ORD

Cidara Therapeutics, Inc. is a biotechnology company. The Company is focused on the discovery, development and commercialization of therapeutics designed for patients facing serious diseases. The Company's lead product candidate is rezafungin acetate, an intravenous formulation of an echinocandin. Rezafungin is being developed as a once-weekly, high-exposure therapy for the treatment and prevention of serious invasive fungal infections. The Company’s primary focus is using its Cloudbreak platform to develop a potential new class of drugs called drug-Fc conjugates (DFCs), for the prevention and treatment of serious diseases. This technology couples’ potent inhibitors to a human antibody fragment to create long-acting DFCs designed to inhibit multiple disease targets. Its advanced DFC program is CD388, a long-acting antiviral designed to deliver universal prevention and treatment of seasonal and pandemic influenza, which is in Phase I and Phase IIa clinical trials.

Read More
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CDTX Price Commentary

Write your thoughts about Cidara Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email